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Aim: We compared the weight of the prostate specimen extracted after radical prostatectomy with preoperatively estimated weights of
the prostate by different imaging techniques.
Materials and methods: Prostate weights were estimated by transabdominal ultrasonography (TAUS), transrectal ultrasonography
(TRUS), and computed tomography (CT) preoperatively before radical prostatectomy. Prostatectomy specimens were weighed
postoperatively and the actual prostate weights were calculated. Statistical analyses were done using 95% confidence intervals with
repeated measurement analysis of variance and intraclass correlation coefficients.
Results: Of the 163 patients enrolled in the study, the mean age was 64.2 ± 6.4 (range: 45 to 76) years. The mean postoperative prostate
weight was 54.7 ± 27.9 g. Preoperative mean prostate volumes calculated by TAUS, TRUS, and CT were 50.2 ± 24.1, 50.7 ± 24.6, and
62.7 ± 28.2 mL, respectively (P < 0.001). The actual prostate weight measured using an electronic scale was correlated with the estimated
prostate weight in each of 3 methods, the best of which was that of TRUS.
Conclusion: The actual prostate weight is best estimated by measurements done with TRUS. However, clinicians should consider that
some errors and deviations may occur with these imaging techniques.
Key words: Prostate, prostate volume, ultrasound, transrectal ultrasonography, computed tomography

1. Introduction
Benign prostatic hyperplasia (BPH) is one of the most
common diseases in older men. The new studies on
the natural course of the disease revealed that BPH is a
progressive disease (1). Prostate cancer is one of the
most commonly seen malignancies in older men (2,3).
Age, prostate-specific antigen (PSA), prostate volume,
and symptoms were used to assess the risk of disease
progression, but the 2 most deeply investigated risk
factors are PSA and prostate volume (4). Prostate volume
is an important parameter in diagnosis and treatment of
both benign and malign prostate disease (5,6). For BPH,
prostate volume is important in predicting response to
5α-reductase therapy and is also used to select which
surgical treatment modality is the best for the patient
(7,8). In calculating PSA density, prostate volume is used
as the denominator (9). If there is a problem deciding on
the number of cores to be removed, prostate volume is
involved again (10). A preference for the use of perineal,
* Correspondence: saltinova@yahoo.com

robotic, or retropubic approaches is also based on the
prostate volume (11,12). Lastly, prostate volume is used
for calculating the radiotherapy doses to be delivered in
external beam or brachytherapy, and in planning therapies
such as high-intensity focused ultrasound for prostate
cancer (13,14).
Our aim is to compare the actual weight of surgically
removed prostate tissue with the estimated weight by
transrectal ultrasonography (TRUS), transabdominal
ultrasonography (TAUS), and computed tomography (CT)
and to determine the best estimating radiological methods
in making diagnostic and treatment decisions in patients
with benign and malignant prostatic diseases.
2. Materials and methods
Patients with a diagnosis of prostate adenocarcinoma
who underwent radical prostatectomy between January
2005 and June 2009 at the Ankara Atatürk Training and
Research Hospital First Urology Clinic were enrolled in
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3. Results
The mean age of the patients undergoing radical
prostatectomy for prostate carcinoma was 64.2 ± 6.4
(range: 45–76) years at the time of surgery. The final PSA
levels within 1 month before surgery were within the
interval of 10.6 ± 7.7 ng/mL. Apart from 13 patients who

underwent perineal prostatectomy and 4 patients who
underwent robot-assisted laparoscopic prostatectomy,
the remaining 146 patients underwent radical retropubic
prostatectomy procedures.
The average actual prostate weight was measured as
54.7 ± 27.9 g using an electronic scale. The average prostate
volumes measured with TAUS, TRUS, and CT were 50.2 ±
24.1, 50.7 ± 24.6, and 62.7 ± 28.2 mL, respectively (Figure 1).
The estimated prostate weights obtained by TAUS and
TRUS were lower (8.2% and 7.3%, respectively) when
compared with the actual prostate weights, whereas the
estimated prostate weights were higher when CT was used
to calculate the prostatic weights (14.6%). The difference
between the actual prostate weight and the estimated
prostate weights measured by TAUS, TRUS, and CT was
statistically significant (P < 0.001) (Table 1).
Weight estimated by CT compared with the actual
prostate weight yielded the best estimates when the actual
prostatic weight was over 80 g (average weight difference
for actual prostatic weights ≤40 g of +11.7, between 41
and 60 g of +9.1, between 61 and 8 0 g of +6.0, and >80
g of –2.6). However, in the group with an actual prostate
weight of ≤40 g, the best estimation was achieved by TRUS
(average difference of weight for TRUS of –0.2, for TAUS
of +2.6, and for CT of +11.7) (Table 2; Figure 1).
The average actual weights for patients 60 or younger
(n = 46, range: 45–60) and older than 60 (n = 117, range:
61–76) were 48.1 ± 24.1 g and 57.2 ± 28.9 g, respectively.
Prostate weight (g)

the study. Patients who were treated with transurethral
prostatectomy, androgen deprivation, or radiation therapy
were excluded.
In the 163 patients who matched the criteria, prostate
volumes were measured by TRUS (B-K, Denmark), TAUS
(B-K, Denmark), and CT, with all volumes calculated
using an ellipsoid formula. The volumes measured by
TRUS, TAUS, and CT were compared with the weight of
the surgically removed prostate specimen directly, because
the specific gravity of the prostate gland is 1.050.
The prostate volumes measured preoperatively by
TRUS, TAUS, and CT were compared with the weight of
the surgically removed specimen, including the seminal
vesicles and vas deferens, using an electronic scale within 5
min after removal and just before fixation within formalin.
TRUS was done in our clinic by only one surgeon (SA)
and all other radiological techniques were done by the
same radiologist. Seminal vesicles were not removed from
the surgical specimen so as not to compromise pathologic
evaluation.
Because of the fact that all cancers of the prostate are
significant under the age of 60, we divided the patients into
2 groups according to age: 60 years or under, and over 60
years. Repeated measurement analysis of variance was used
to determine whether there was any statistically significant
difference between actual prostate weight, and the prostate
weight estimated by TAUS, TRUS, and CT. In the cases where
a significant difference was seen in repeated measurement
analysis of variance, a correcting Bonferroni multiple
comparison test was used to determine the condition that
caused the difference. An intraclass correlation coefficient
with 95% confidence interval was used to understand if the
actual prostate weight and the prostate weights estimated by
TAUS, TRUS, and CT were compatible.
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Figure 1. Actual weight and estimated weight levels measured by
imaging methods according to the weight of the prostate.

Table 1. Actual weight, average prostate weight measured by imaging techniques, and 95% confidence interval for all cases.
Variables

Mean weight (g)

95% Confidence interval

Mean weight
difference (g)

Percentage of mean weight
difference (%)

TAUS

50.2 ± 24.1

0.838 (0.774–0.883)

–4.5

–8.2

TRUS

50.7 ± 24.6

0.898 (0.835–0.933)

–4

–7.3

BT

62.7 ± 28.2

0.780 (0.653–0.855)

+8.0

+14.6

Actual weight

54.7 ± 27.9

P

<0.001
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Table 2. Actual weight and estimated weight levels measured by imaging methods according to the weight of the prostate.
>80 g (n = 23)

–4.3

-8.9

60.9 ± 13.3

–7.4

-10.8

96.8 ± 21.9

–11.6

–10.7

CT

43.4 ± 15.1

+11.7

+36.9

57.0 ± 15.4

+9.1

+19.9

74.3 ± 18.9

+6

+8.8

105.6 ± 34.5

–2.8

–2.6

Actual weight

31.7 ± 6.3

47.9 ± 5.5

68.3 ± 5.3

108.4 ± 29.9

P

<0.001

<0.001

<0.001

0.002

Prostate weight (g)

(g)

120
100
80
60
40
20
TAUS

TRUS
Age 41–60

CT

(g)

4. Discussion
In this study, we compared the prostate volumes measured
by TRUS, TAUS, and CT with the actual weight measured
after prostatectomy by using the data from our own clinic
in patients undergoing radical prostatectomy.
In our study, the seminal vesicles and vas deferens were
not removed before measuring the weight of the surgical
specimen on the electronic scale so as not to compromise
pathological evaluation. In an earlier study, Rodriguez
et al. (15) reported that seminal vesicles contribute an
average of 3.8. g to the weight (range: 2.2 to 4.6). Referring
to the actual prostatic weight in this study (54.7 ± 27.9 g),
we believe that the inclusion of the seminal vesicles and
vas deferens in the measurement of prostatic weight did
not cause a significant error in our calculations.
The volumes measured by TRUS, TAUS, and CT
were compared with the weight of the surgically removed
prostate specimen directly, because the specific gravity of
the prostate gland is 1.050 (15). The weights measured
with TAUS and TRUS were seen to correlate well with
actual prostate weight (0.898 and 0.838) despite being

The average weights obtained by TAUS, TRUS, and CT
were 44.8 ± 19.5, 44.8 ± 23.2, and 52.2 ± 20.6 and 52.2 ±
25.5, 52.7 ± 24.9, and 66.5 ± 29.8 for patients aged ≤60 and
>60 years, respectively (Table 3).
The difference between the actual prostate weights
and the weights measured with imaging methods
were statistically significant (P = 0.002 and P < 0.001,
respectively) (Table 3; Figure 2).

0
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Average difference
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of weight (g)
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Average weight

59.4 ± 15.3

of weight %

–6.3

Average difference

–3.0

of weight (g)

44.9 ± 11.8

Average difference

+8.2

Average weight

+2.6
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≤40 g (n = 52)

Postoperational
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Figure 2. Actual prostate weights and the weight measured by
imaging techniques according to age groups

Table 3. Actual prostate weights and the weight measured by imaging techniques according to age groups
Variables

Age ≤60 (n = 46)

Age >61 (n = 117)

Average (g)

Difference (g)

%

Average (g)

Difference (g)

%

TAUS

44.8 ± 19.5

–3.3

–6.9

52.2 ± 25.5

–5

–8.7

TRUS

44.8 ± 23.2

–3.3

–6.9

52.7 ± 24.9

–4.5

–7.9

BT

52.2 ± 20.6

+4.1

+8.5

66.5 ± 29.8

-9.3

+16.3

Actual weight

48.1 ± 24.1

57.2 ± 28.9

P

0.002

<0.001
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estimated as lower than the actual weight (8.2% and 7.3%).
On the other hand, CT correlated well with the actual
weight (0.780), despite estimating it to be 15% larger than
the actual weight.
Sajadi et al. compared the prostate weight measured
with TRUS and the weight of the excised specimen in
497 patients who underwent radical prostatectomy (16).
They reported that TRUS is an imperfect alternative with
significant errors. They reported that more accurate results
were obtained with large prostates (above 40 g). In our
study, the compliance rate of TRUS was 0.744, and more
accurate results were obtained with prostates heavier than
80 g on the scale. Sajadi et al. associated the error rates
in TRUS with measurement errors. Furthermore, they
reported that prostate weight may decrease before fixation
due to loss of blood during radical prostatectomy, and
because seminal vesicles and vasal ends contribute to
the weight and these cannot be measured with imaging
techniques (16).
In our study, the estimated weight was always lower
than the actual weight with TAUS and TRUS, whereas
with CT the estimated weight was higher than the actual
prostate weight, except for the group with prostates heavier
than 80 g. Kälkner et al. compared CT and TRUS prostate
volumes of patients who were to be treated with conformal
radiotherapy and brachytherapy combination for localized
prostate cancer (17). They observed that prostate volumes on
CT were 48% greater than the prostate volumes calculated
with the TRUS ellipse formula. They reported that the angle
of cross-section affected the measured prostate volume.
We performed TAUS and CT with patients in the supine
position and TRUS in the left lateral decubitis position
with knees pulled up to the abdomen. In more horizontal
sections the anterior-posterior dimension increases,
whereas the cranio-caudal size decreases. However, Kälkner
et al. noted that this cross-sectional angle difference cannot
fully explain the variations in size alone (17).
Another reason for the incorrect measurements
with abdominal or transrectal ultrasonography may be

the doctor’s experience and the device used. Kim et al.
calculated prostate volume with TRUS performed by
3 radiologists with different experience levels (novice,
trained, and specialist) by using transrectal ultrasounds
and abdominal ultrasounds in 94 patients and using
transrectal ultrasounds and 3-dimensional ultrasounds
in 54 patients. They reported that experience is an
important factor in calculating the prostate volume with
ultrasonography (USG) and that bladder volume during
the measurement is not important (18).
Huang Foen Chung et al. measured prostatic weights
in 100 patients. In the first group, TAUS and TRUS were
performed. In the second group, 2 different devices were
used for transabdominal measurements. Transrectal
USG was performed by 3 researchers whereas the
transabdominal USG examinations were performed by the
same investigator. No significant differences were found
between TAUS and TRUS measurements within the first
group, between transabdominal measurements using 2
devices, or between results of different investigators (19).
Our study showed that actual prostate weight is best
estimated by TRUS measurement when the radiographic
modalities used as imaging methods are TAUS, TRUS,
and CT. The average weight differences and the percentage
differences in average weights were higher in CT
measurements. As the prostate weight increases, especially
over 80 g, the average weight difference and the percentage
difference in average weights on CT seemed to decrease
compared to those obtained with TAUS and TRUS. As the
prostate weight decreases, especially below 40 g, average
weight difference and the percentage difference in average
weights on TRUS seemed to decrease compared to those of
TAUS and CT. Measuring the prostate volume can be useful
in deciding which technique should be used according to
the pathology. Clinicians should be aware that there may
be errors and deviations in prostatic weights obtained by
imaging methods when planning to use it for diagnostic
purposes and the planning of treatment.

References
1.

Fong YK, Milani S, Djavan B. Natural history and clinical
predictors of clinical progression in benign prostatic
hyperplasia. Cur Opin Urol 2005; 15: 35–8.

2.

Akpolat N, Büyük Y, Uzun İ, Geçit İ, Kurnaz G. Prevalence of
latent prostate cancer and prostatic intraepithelial neoplasia in
İstanbul, Turkey: an autopsy study. Turk J Med Sci 2012; 42:
449–56.

3.

Gülkesen HK, Köksal İT, Özdem S, Saka O. Prediction of
prostate cancer using decision tree algorithm. Turk J Med Sci
2010; 40: 681–6.

34

4.

Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson
PB, Malek GH, Schellhammer PF, Bruskewitz R, Matsumoto
AM, Harrison LH et al. Serum prostate specific antigen is a
strong predictor of future prostate growth in men with benign
prostatic hyperplasia. PROSCAR long-term efficacy and safety
study. J Urol 2000; 163: 13–20.

5.

Hoffelt SC, Marshall LM, Garzotto M, Hung A, Holland J,
Beer TM. A comparison of CT scan to transrectal ultrasoundmeasured prostate volume in untreated prostate cancer. Int J
Radiat Oncol Biol Phys 2003; 57: 29–32.

KILIÇ et al. / Turk J Med Sci
6.

7.

Uğurlu Ö, Çetinkaya M, Özden C, Öztekin ÇV, Akdemir AÖ,
Memiş A, Yarış M. An abnormal digital rectal examination is an
independent predictor of high radical prostatectomy Gleason’s
score ( ≥7) in patients with clinically localized prostate cancer.
Turk J Med Sci 2009; 39: 755–60.

13.

Pinkawa M. External beam radiotherapy for prostate cancer.
Panminerva Med 2010; 52: 195–207.

14.

Strom KH, Gu X, Spaliviero M, Wong C. The effects of
5α-reductase inhibition on benign prostatic hyperplasia
treated by photoselective vaporization prostatectomy with the
120 Watt GreenLight HPS laser system. J Am Coll Surg 2011;
212: 244–50.

Ahmed HU, Zacharakis E, Dudderidge T. High-intensityfocused ultrasound in the treatment of primary prostate
cancer: the first UK series. Br J Cancer 2009; 101: 19–26.

15.

Rodriguez E Jr, Skarecky D, Narula N, Ahlering TE. Prostate
volume estimation using the ellipsoid formula consistently
underestimates actual gland size. J Urol 2008; 179: 501–3.

16.

Sajadi KP, Terris MK, Hamilton RJ, Cullen J, Amling CL, Kane
CJ, Presti JC Jr, Aronson WJ, Freedland SJ. Body mass index,
prostate weight and transrectal ultrasound prostate volume
accuracy. J Urol 2007; 178: 990–5.

17.

Kälkner KM, Kubicek G, Nilsson J, Lundell M, Levitt S,
Nilsson S. Prostate volume determination: differential volume
measurements comparing CT and TRUS. Radiother Oncol
2006; 81: 179–83.

18.

Kim SH, Kim SH. Correlations between the various methods
of estimating prostate volume: transabdominal, transrectal,
and three-dimensional US. Korean J Radiol 2008; 9: 134–9.

19.

Huang Foen Chung JW, de Vries SH, Raaijmakers R, Postma
R, Bosch JL, van Mastrigt R. Prostate volume ultrasonography:
the influence of transabdominal versus transrectal approach,
device type and operator. Eur Urol 2004; 46: 352–6.

8. Watanabe H, Igari D, Tanahashi Y, Harada K, Saito M.
Measurements of size and weight of the prostate by means of
transrectal ultrasonotomography. Tohoku J Exp Med 1974;
114: 277–85.
9.

Nogueira L, Corradi R, Eastham JA. Prostatic specific antigen
for prostate cancer detection. Int Braz J Urol 2009; 35: 521–9.

10.

Ochiai A, Troncoso P, Chen ME. The relationship between
tumor volume and the number of positive cores in men
undergoing multisite extended biopsy: implication for
expectant management. J Urol 2005; 174: 2164–8.

11.

Canda AE, Atmaca AF, Akbulut Z, Asil E, Kılıç M, İsgören
AE, Balbay MD. Results of robotic radical prostatectomy in
the hands of surgeons without previous laparoscopic radical
prostatectomy experience. Turk J Med Sci 2012; 42 (Sup. 1):
1338–46.

12.

Mouraviev V, Nosnik I, Sun L. Financial comparative analysis
of minimally invasive surgery to open surgery for localized
prostate cancer: a single-institution experience. Urology 2007;
69: 311–4.

35

